NanoViricides Inc. (NNVC)

[changes_iv]

I understand what you say, I did however write to the U.S. Congress just to add one more voice. Nanoviricides, Inc. is a start-up company, with great science, with great potential to solve health related economic problems as well as health threats to this country and abroad. It makes no sense to take away Orphan Drug Designation tax credit. If the U.S. takes the tax credit out, in essence they are taxing. Our government, our nation, is in great need of revenue to overcome the deficit and start to pay our national debt. There is a commonsensical solution, as Thomas Sowell puts it, "The real goal should be reduced government spending, rather than balanced budgets achieved by ever rising tax rates to cover ever rising spending."

The Orphan Drug designation tax credit is money that will not be collected by the tax agency if let alone while, at least in the case of Nanoviricides, Inc., billions of dollars of stress on personal savings, Social Security, and Medicare each year could be alleviated. And the “cost” of illness — both in dollars and pain? That as well.

Any good they tax, and we will get less of it. The U.S. Congress should hear from all of us, investors and any future beneficiaries of Nanoviricides, Inc. science.